Intuitive Surgical, Inc. released unaudited financial statements for the third quarter of 2021 and the nine-month period, detailing total assets of $12.93 billion, liabilities of $1.47 billion, and stockholders' equity of $11.46 billion as of September 30, 2021. The company recorded revenue of $1.4 billion for the quarter, resulting in a net income of $387.2 million, and $1.35 billion for the nine-month period. Cash flow from operating activities was $1.52 billion, with investing activities at $1.82 billion and financing activities providing $24.4 million for the nine-month period. The financial information also delves into long-term liabilities, revenue disaggregation, remaining performance obligations, and legal risks related to product liability and patent litigation cases faced by the company due to ongoing COVID-19-related challenges affecting its operations.
The text provides a comprehensive analysis of Intuitive Surgical, Inc., covering the impact of the COVID-19 pandemic on the company's operations and financial performance. It details the fluctuation of da Vinci procedures in different regions during 2020 and 2021, as well as the company's focus on advancing patient care through robotic-assisted surgical technology. Additionally, the text discusses the progression of COVID-19 impacts on the company's procedures, including recovery trends and regional variations. Furthermore, the text delves into Intuitive Surgical's products, procedures, distribution channels, regulatory activities, and global procedures. It highlights the company's offering of advanced surgical instruments and systems like da Vinci X and SP Surgical Systems for different specialties, as well as its adherence to international standards and regulations. The discussion also includes the company's focus on procedure efficacy and minimally-invasive surgery across various specialties, alongside recent business events showcasing growth in total da Vinci procedures, particularly in general surgery, urology, and gynecology procedures.
The text provided states that there have been no significant changes in the market risk for the company during the nine months ending September 30, 2021, compared to the disclosures made in their Annual Report for the year ended December 31, 2020.
The text discusses the evaluation of disclosure controls and procedures implemented by a company to ensure timely and accurate reporting of information in Exchange Act reports as required by SEC rules. The company's principal executive officer and principal financial officer conducted an evaluation and concluded that the controls and procedures were effective. Additionally, there were no significant changes in internal control over financial reporting during the most recent fiscal quarter.
The text provided references incorporating information from Note 8 of the Condensed Consolidated Financial Statements (Unaudited) in a quarterly report. This information likely pertains to legal proceedings mentioned in the financial statements.
The text discusses various risk factors related to the business operations of a company, particularly regarding reliance on sole and single-source suppliers for materials, parts, and components. It emphasizes the potential harm to meeting product demand, revenues, and brand reputation if supply disruptions occur. Additionally, concerns about cybersecurity attacks, the protection of sensitive data, and potential risks of data breaches are highlighted. The text underscores the importance of effective information technology systems to sustain business functions and operations, including customer relations and financial conditions, while acknowledging the challenges and potential consequences of security breaches or technology vulnerabilities.
The text discusses the issuer's summary of stock repurchase activities during the quarter ended September 30, 2021. It reports that there were no unregistered sales of equity securities during the period. The company had a stock repurchase program in place since March 2009, with an aggregate authorization of up to $7.5 billion for repurchases. As of September 30, 2021, $1.6 billion remained available under the authorized repurchase program.
The text provided does not mention any defaults on senior securities.
The text provided states that there are no mine safety disclosures applicable in the given context.
There is no additional information provided.
The text provides a list of exhibits related to Intuitive Surgical, Inc., including their amended certificate of incorporation, bylaws, certifications of executives, and financial reports. It also includes a signature and date for the report filing on October 20, 2021.
